Abstract
According to recent clinical trials, adjuvant therapy with fluorouracil (Adrucil) plus levamisole increases the overall survival rate for patients with Dukes' stage C colon cancer. As a result of these findings, the National Cancer Institute has advocated use of this treatment option for eligible patients. Widespread use of this regimen may save many lives.
Original language | English |
---|---|
Pages (from-to) | 79-80 |
Number of pages | 2 |
Journal | Postgraduate Medicine |
Volume | 88 |
Issue number | 5 |
DOIs | |
State | Published - 1990 |
Keywords
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Colonic Neoplasms/drug therapy
- Fluorouracil/administration & dosage
- Humans
- Levamisole/administration & dosage
- Prognosis